This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Falchetti, M. L. Articles by Pallini, R. Search for Related Content PubMed PubMed Citation Articles by Falchetti, M. L. Articles by Pallini, R.

Glioblastoma Induces Vascular Endothelial Cells to Express Telomerase in Vitro¹

Institutes of Neurobiology and Molecular Medicine [M. L. F., A. L.] and Cell Biology [P. C.], Consiglio Nazionale delle Ricerche, Rome 00137 and Institutes of Human Pathology [F. P., N. M., L. M. L.] and Neurosurgery [R. P.], Catholic University, Rome 00168, Italy

Angiogenesis is essential for the growth of solid tumors. We have observed previously that the vascular endothelial cells of astrocytic brain tumors express human telomerase reverse transcriptase (hTERT) mRNA, suggesting a role for telomerase in the angiogenesis of these neoplasms. Here, we used an in vitro model to demonstrate that the telomerase machinery might be trans-activated in primary endothelial cells by glioblastoma tumor cells. We found that glioblastoma cells in vitro do induce hTERT mRNA and hTERT protein expression, as well as telomerase enzyme activity in the endothelial cells, and that this phenomenon is mediated by diffusible factor(s). These results provide strong evidence of the involvement of telomerase in tumor angiogenesis and will stimulate research on antitelomerase drugs for treatment of malignant brain gliomas.

This article has been cited by other articles:

				R. Pallini, L. Ricci-Vitiani, G. L. Banna, M. Signore, D. Lombardi, M. Todaro, G. Stassi, M. Martini, G. Maira, L. M. Larocca, et al. Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme Clin. Cancer Res., December 15, 2008; 14(24): 8205 - 8212. [Abstract] [Full Text] [PDF]

				J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF]

				Y.-L. Wu, C. Dudognon, E. Nguyen, J. Hillion, F. Pendino, I. Tarkanyi, J. Aradi, M. Lanotte, J.-H. Tong, G.-Q. Chen, et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths J. Cell Sci., July 1, 2006; 119(13): 2797 - 2806. [Abstract] [Full Text] [PDF]

				G. De Stasio, D. Rajesh, J. M. Ford, M. J. Daniels, R. J. Erhardt, B. H. Frazer, T. Tyliszczak, M. K. Gilles, R. L. Conhaim, S. P. Howard, et al. Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei Clin. Cancer Res., January 1, 2006; 12(1): 206 - 213. [Abstract] [Full Text] [PDF]

				M. D. Edo and V. Andres Aging, telomeres, and atherosclerosis Cardiovasc Res, May 1, 2005; 66(2): 213 - 221. [Abstract] [Full Text] [PDF]

				E. Pascale, G. C. Reale, and E. D'Ambrosio Tumor Cells Fail to trans-Induce Telomerase in Human Umbilical Vein Endothelial Cell Cultures Cancer Res., November 1, 2004; 64(21): 7702 - 7705. [Abstract] [Full Text] [PDF]

				A. L. Serrano and V. Andres Telomeres and Cardiovascular Disease: Does Size Matter? Circ. Res., March 19, 2004; 94(5): 575 - 584. [Abstract] [Full Text] [PDF]